USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.

Chandrasekaran AP, Kaushal K, Park CH, Kim KS, Ramakrishna S
Theranostics. 2021 Sep 27;11(20):9752-9771. doi: 10.7150/thno.63806. eCollection 2021. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.